Bharat Biotech to use ViroVax's adjuvant in Covid vaccine

Bharat Biotech has teamed up with ViroVax to use the US scientific research firm’s adjuvant for boosting the immune response and providing long-lasting immunity to its novel vaccine candidate Covaxin, which has entered phase-2 human trials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Gk6wkz
via IFTTT